Overview

Therapeutic Drug Monitoring of Anxiolytics in Children

Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
In this study, the therapeutic drug monitoring of anxiolytics is carried out among children to obtain the drug concentration, clinical efficacy and safety data of children patients in different gender and age groups. Then the investigators analyze the relationship between blood drug concentration and efficacy and safety, and provide recommendations for the treatment window of anxiolytics in Chinese children.
Phase:
Phase 4
Details
Lead Sponsor:
Wei Zhao
Treatments:
Anti-Anxiety Agents
Diazepam
Midazolam
Propofol